Kemwell is a leading biologics CDMO in Asia which provides services to global biopharmaceutical organizations.
We have development as well as manufacturing capabilities - both DS and DP.
Expertise - mAbs, bi-specifics antibodies, fusion proteins, recombinant subunit vaccine, etc.

Currently manufacturing one commercial drug substance and two drug products. Apart from commercial manufacturing, we executed 8 process development and clinical manufacturing projects during last 3 years.  Most advance project is in Phase III CT in USA. 

Look forward to meeting biotech companies during this event and exploring their outsourcing needs.